<DOC>
	<DOC>NCT00221611</DOC>
	<brief_summary>Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales</brief_summary>
	<brief_title>Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity</brief_title>
	<detailed_description>Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>CP patients with therapyresistent spasticity Patients with sufficient body weight in relation to the volume Oral medication has failed: insufficient effect or too many sideeffects The patient and family understand the objectives of the treatment and accept those objectives Informed Consent Contraindications for surgery (e.g. infection) Hypersensitivity to oral Baclofen</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>